LCTX vs LYV · rev $2.8M vs P/E 49, rev $11.46B
Lineage Cell Therapeutics Inc (LCTX) versus Live Nation Entertainment Inc (LYV) — a side-by-side from cached financials, not a winner call.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Live Nation Entertainment Inc (LYV) is a entertainment company listed on US.
Latest reported LCTX revenue for 2026-06-30 was $2.8M. Net income was -$3.3M. Revenue was up 62.0% from 2026-03-31 to 2026-06-30. LCTX currently screens at market cap $213.6M.
Latest reported LYV revenue for 2026-06-30 was $11.46B. Net income was -$94.7M. LYV currently screens at market cap $33.36B and trailing P/E 48.8.
LCTX currently screens at market cap $213.6M. LYV currently screens at market cap $33.36B and trailing P/E 48.8.
Not investment advice. Open the LCTX and LYV stock pages for the full models.
Not investment advice.